[HTML][HTML] Receptors involved in mental disorders and the use of clozapine, chlorpromazine, olanzapine, and aripiprazole to treat mental disorders

R Mlambo, J Liu, Q Wang, S Tan, C Chen - Pharmaceuticals, 2023 - mdpi.com
Mental illnesses are a global health challenge, and effective medicines are needed to treat
these conditions. Psychotropic drugs are commonly prescribed to manage mental disorders …

Effects of antipsychotics on the gastrointestinal microbiota: a systematic review

MF Dias, YJ de Almeida Nogueira, MA Romano-Silva… - Psychiatry …, 2024 - Elsevier
Antipsychotics (APs) have been increasingly prescribed for psychiatric disorders from
schizophrenia to disruptive behavioral conditions. These drugs have been associated with …

[HTML][HTML] Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia

Z Feng, Z Hu, L Li, M Yu, Y Zhang, P Jing… - Frontiers in …, 2024 - frontiersin.org
Background: Schizophrenia is a serious psychiatric disorder that significantly affects the
quality of life of patients. The objective of this study is to discover a novel antipsychotic …

Aripiprazole and its adverse effects in the form of impulsive-compulsive behaviors: A systematic review of case reports

M Akbari, S Jamshidi, S Sheikhi, F Alijani… - …, 2024 - Springer
Aripiprazole is an efficacious treatment for both the positive and negative symptoms of
schizophrenia and is also commonly used as a mood stabilizer. It is associated with better …

[HTML][HTML] Bioequivalence prediction with small-scale biphasic dissolution and simultaneous dissolution-permeation apparatus—An aripiprazole case study

S Kádár, A Kennedy, S Lee, R Ruiz, A Farkas… - European Journal of …, 2024 - Elsevier
Both biphasic dissolution and simultaneous dissolution-permeation (DP) systems have great
potential to improve the in vitro-in vivo correlation compared to simple dissolution assays …

In Vitro/In Vivo Assessment of Aripiprazole-Loaded Thiolated Arabinoxylan based Nanoparticles: An Innovative Approach for Targeted Schizophrenia Therapy

M Sikander, UR Tulain, NS Malik, A Mahmood, A Erum… - bioRxiv, 2024 - biorxiv.org
This study was conducted with the primary objective of improving the bioavailability of
aripiprazole (APZ) through the development of nanoparticles using thiolated arabinoxylan …

[HTML][HTML] Investigating the Excessive Sweating Induced by Aripiprazole: Two Case Reports

SH Hosseini, H Ghazvini… - Pharmaceutical and …, 2024 - pbr.mazums.ac.ir
Aripiprazole is a third-generation atypical antipsychotic medication used for different
psychiatric disorders [1]. It is a partial agonist at the dopamine D2 receptor, a partial agonist …

Current targets and treatments of schizophrenia

Y Ding, H Gao, Z Liu, X Xu - Highlights in Science, Engineering and …, 2023 - drpress.org
With the improvement of the level of social and economic development, mental illness has
received more and more attention and attention. Among them, schizophrenia, as a common …